COMMUNICATION
News & Press Release
Total 122
-
12Neurobiogen, a patent registration for a structure for preventing and treating damage to the spinal
DATE : 2021-02-08
VIEW : 2716
-
11Start-ups speeding up the development of new Alzheimer's drugs, delayed brain degeneration.
DATE : 2021-01-31
VIEW : 2767
-
10Neurobiogen presents new possibilities with dementia treatment KDS2010.
DATE : 2020-11-18
VIEW : 2744
-
9Brain Cleaner's Cell Tracking...I found the cause of dementia.
DATE : 2020-11-17
VIEW : 2798
-
8Neurobiogen, applied for FDA ODD(Orphan Drug Designation) for 'Acute Spinal Cord Injury' treatment,
DATE : 2020-09-02
VIEW : 2833
-
7Uncover the secret of stroke that remains symptoms even after treatment...“Confirmed the efficacy of
DATE : 2020-07-08
VIEW : 2549
-
6World's first investigation into the cause of stroke sequelae...Clinical trial of the treatment will
DATE : 2020-07-08
VIEW : 2587
-
5NEUROBIOGEN, a new drug candidate,'KDS2010' registered for a patent in China.
DATE : 2020-06-24
VIEW : 2631
-
4NEUROBIOGEN completes patent registration in the US and Canada for new drug development substance.
DATE : 2020-03-30
VIEW : 2639
-
3NEUROBIOGEN, start developing new obesity drug 'KDS2010'.
DATE : 2020-03-17
VIEW : 2617
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved